Total Payments
$96,033
2024 Payments
$2,197
Companies
43
Transactions
699
Medicare Patients
7,662
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$80,784 (84.1%)
Food & Beverage$12,974 (13.5%)
Travel$2,109 (2.2%)
Education$165.72 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80,784 | 34 | 84.1% |
| Food and Beverage | $12,974 | 639 | 13.5% |
| Travel and Lodging | $2,109 | 20 | 2.2% |
| Education | $165.72 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $42,967 | 164 | $0 (2024) |
| GlaxoSmithKline, LLC. | $37,445 | 235 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $8,749 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $867.01 | 43 | $0 (2024) |
| Pulmonx Corporation | $655.67 | 2 | $0 (2019) |
| Ethicon Endo-Surgery Inc. | $577.40 | 2 | $0 (2017) |
| PFIZER INC. | $485.83 | 28 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $416.21 | 14 | $0 (2024) |
| GENZYME CORPORATION | $294.08 | 16 | $0 (2024) |
| Electromed, Inc. | $284.47 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,197 | 97 | AstraZeneca Pharmaceuticals LP ($680.21) |
| 2023 | $14,505 | 96 | GlaxoSmithKline, LLC. ($10,850) |
| 2022 | $34,021 | 103 | AstraZeneca Pharmaceuticals LP ($14,035) |
| 2021 | $39,656 | 104 | AstraZeneca Pharmaceuticals LP ($24,851) |
| 2020 | $589.67 | 40 | AstraZeneca Pharmaceuticals LP ($140.79) |
| 2019 | $2,079 | 95 | Pulmonx Corporation ($655.67) |
| 2018 | $1,402 | 85 | GlaxoSmithKline, LLC. ($483.19) |
| 2017 | $1,584 | 79 | Ethicon Endo-Surgery Inc. ($577.40) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: HFCWO | ||||||
| 12/17/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Sleep | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: HFCWO | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,989 | 3,145 | $948,345 | $340,515 |
| 2022 | 19 | 1,817 | 3,375 | $960,229 | $337,057 |
| 2021 | 21 | 1,968 | 3,581 | $974,872 | $351,063 |
| 2020 | 23 | 1,888 | 2,968 | $950,825 | $315,139 |
Total Patients
7,662
Total Services
13,069
Medicare Billing
$1.3M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 384 | 558 | $167,400 | $79,582 | 47.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 213 | 730 | $203,670 | $70,545 | 34.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 120 | 383 | $220,225 | $65,423 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 468 | 538 | $134,500 | $51,498 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 133 | 133 | $56,525 | $23,155 | 41.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 115 | 124 | $49,600 | $17,115 | 34.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 64 | 137 | $34,250 | $11,475 | 33.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 102 | 103 | $40,900 | $7,026 | 17.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 19 | 39 | $11,700 | $4,889 | 41.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 36 | 37 | $14,800 | $4,660 | 31.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 16 | 31 | $1,674 | $1,136 | 67.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 29 | $2,001 | $1,099 | 54.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 91 | 91 | $2,275 | $879.97 | 38.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 99 | 99 | $2,475 | $709.83 | 28.7% |
| 94070 | Test to measure lung airway sensitivity | Facility | 2023 | 30 | 30 | $1,950 | $672.00 | 34.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 72 | 72 | $3,960 | $579.60 | 14.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 11 | 11 | $440.00 | $72.82 | 16.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 145 | 437 | $251,275 | $78,077 | 31.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 249 | 759 | $211,761 | $63,938 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 242 | 391 | $117,300 | $55,080 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 496 | $124,000 | $45,659 | 36.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 115 | 124 | $49,600 | $19,757 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 87 | 87 | $37,013 | $14,615 | 39.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 57 | 122 | $30,500 | $11,023 | 36.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 124 | 128 | $50,150 | $9,163 | 18.3% |
About Dr. Payam Aghassi, MD
Dr. Payam Aghassi, MD is a Internal Medicine healthcare provider based in Leominster, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093704298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Payam Aghassi, MD has received a total of $96,033 in payments from pharmaceutical and medical device companies, with $2,197 received in 2024. These payments were reported across 699 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($80,784).
As a Medicare-enrolled provider, Aghassi has provided services to 7,662 Medicare beneficiaries, totaling 13,069 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy & Immunology, Critical Care Medicine
- Location Leominster, MA
- Active Since 10/19/2005
- Last Updated 04/17/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093704298
Products in Payments
- BREZTRI (Drug) $40,805
- TRELEGY ELLIPTA (Drug) $25,150
- DUPIXENT (Biological) $9,072
- NUCALA (Biological) $912.26
- FASENRA (Biological) $817.29
- Pulmonx Endobronchial Valve EBV (Device) $655.67
- OFEV (Drug) $548.92
- ANORO (Drug) $396.97
- CHANTIX (Drug) $348.73
- AIRSUPRA (Drug) $338.69
- FASENRA (Drug) $300.65
- TEZSPIRE (Biological) $299.28
- BREO (Drug) $297.33
- SYMBICORT (Drug) $289.22
- ANORO ELLIPTA (Drug) $288.08
- SMARTVEST (Device) $284.47
- UPTRAVI (Drug) $255.48
- Wakix (Drug) $198.07
- ACTHAR (Biological) $170.29
- STIOLTO RESPIMAT (Drug) $157.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Leominster
Plutarco Castellanos, Md, MD
Internal Medicine — Payments: $10,766
Internal Medicine $10,766
Dr. Ryan Chua, M.d, M.D
Internal Medicine — Payments: $9,881
Internal Medicine $9,881
Dr. Danilo Funa, M.d, M.D
Internal Medicine — Payments: $8,031
Internal Medicine $8,031
Subasit Acharji, Md, MD
Internal Medicine — Payments: $7,003
Internal Medicine $7,003
Mariann Padron Gleich, M.d, M.D
Internal Medicine — Payments: $5,227
Internal Medicine $5,227
Corey Saltin, Do, DO
Internal Medicine — Payments: $4,246
Internal Medicine $4,246